Medication Brand Name:

Torisel

 
Active Ingredient:
temsirolimus
 
DIN(s) in Canada:
02304104
 
francais
Manufacturer/Distributor:
Wyeth Canada
 
DrugCoverage Category:
Cancer
 
See Also:


Torisel has been approved for sale in Canada for the treatment of metastatic renal cell carcinoma. Torisel is an eligible benefit through some private insurance plans, some provincial and federal programs and is being reviewed for funding by other provincial/ territorial programs and federal plans. The Torisel Access Program (1-877-482-7457) will research and investigate reimbursement options for patients.

Product Monograph
 
Coverage/Reimbursement by Private Insurance Plans in Canada
Torisel may be covered by private insurance plans. Some plans require special authorization / prior authorization before granting reimbursement. The Torisel Access Program (1-877-482-7457) will research and investigate private reimbursement options for patients.
 
Coverage/Reimbursement by Canadian Provincial/Territorial Programs
Province Coverage Program / Eligibility Criteria
Alberta AB Under Review Torisel is currently under review by the provincial drug program.
British Columbia BC Covered Torisel is covered according to eligibility criteria established by the BC Cancer Agency.
Manitoba MB Under Review Torisel is currently under review by the provincial drug program.
New Brunswick NB Under Review Torisel is currently under review by the provincial drug program.
Newfoundland & Labrador NL Covered Torisel is covered according to eligibility criteria by individual Newfoundland and Labrador hospitals.
Northwest Territories NT Under Review Torisel is currently under review by the territorial drug program.
Nova Scotia NS Covered Torisel is covered according to eligibility criteria established by Cancer Care Nova Scotia.
Nunavut NU Under Review Torisel is currently under review by the territorial drug program.
Ontario ON Covered Torisel is covered according to eligibility criteria by Cancer Care Ontario.
Prince Edward Island PE Under Review Torisel is currently under review by the provincial drug program.
Quebec QC Under Review Torisel is currently under review by the provincial drug program.
Saskatchewan SK Covered Torisel is covered according to eligibility criteria established by The Saskatchewan Cancer Agency.
Yukon Territory YT Under Review Torisel is currently under review by the territorial drug program.
 
Coverage/Reimbursement by Canadian Federal Plans
Plan Coverage Program / Eligibility Criteria
Public Services Health Care Plan Possible Coverage Torisel may be covered by The PSHCP
Non-Insured Health Benefits Under Review Torisel coverage is under review by the NIHB
Veterans Affairs Canada Under Review Torisel coverage is under review by Veterans Affairs Canada
 
Health Canada Drug Product Database Listing